Cancer Prevention Laboratory, Colorado State University, Fort Collins, Colorado 80523, USA.
Cancer Prev Res (Phila). 2010 Nov;3(11):1484-92. doi: 10.1158/1940-6207.CAPR-10-0078. Epub 2010 Sep 28.
The purpose of this investigation was to identify pathways by which physical activity, implemented as running in an activity wheel, inhibits carcinogenesis. The focus of this analysis was on 20 plasma biomarkers for glucose homeostasis, inflammation, cytokine function, and endocrine activity, known to be affected by a physically active lifestyle. Plasma for analysis was obtained from previously reported carcinogenesis experiments in which the effects on mammary carcinogenesis, induced by i.p. injection of 1-methyl-1-nitrosurea, of running on a motorized activity wheel or a nonmotorized free wheel were compared with sedentary controls. Wheel running reduced cancer incidence (P = 0.0004) and the number of cancers per animal (P = 0.005). Principal components analysis was used to reduce the 20 plasma biomarkers to a concise index that was significantly different by treatment group assignment (P < 0.0001). Statistical analyses provided evidence that supported the hypothesis of a mediational role of these molecules in accounting for the protective effect of wheel running on the carcinogenic process. In addition, the plasma biomarker index derived from principal components analysis was a good discriminator of treatment group assignment (only 4.5% of animals were misclassified). These findings suggest that the plasma biomarkers evaluated have utility in assessing the breast cancer response to a physical activity intervention. Identification of such biomarkers is critical in clinical studies for which evaluating the effects of physical activity on cancer outcomes (diagnosis, recurrence, or mortality) is not possible.
本研究旨在确定运动(以活动轮跑步的形式实施)抑制致癌作用的途径。本分析的重点是 20 种与葡萄糖稳态、炎症、细胞因子功能和内分泌活动相关的血浆生物标志物,这些生物标志物已知受积极生活方式的影响。用于分析的血浆取自先前报道的致癌实验,其中比较了在电动活动轮或非电动自由轮上跑步对腹腔注射 1-甲基-1-亚硝脲诱导的乳腺致癌作用的影响与久坐对照。轮跑降低了癌症发病率(P=0.0004)和每只动物的癌症数量(P=0.005)。主成分分析将 20 种血浆生物标志物简化为一个简明指数,该指数因治疗组分配而显著不同(P<0.0001)。统计分析为这些分子在解释轮跑对致癌过程的保护作用方面的中介作用假设提供了证据。此外,主成分分析得出的血浆生物标志物指数是治疗组分配的良好判别器(只有 4.5%的动物被错误分类)。这些发现表明,评估的血浆生物标志物可用于评估身体活动干预对乳腺癌的反应。在评估身体活动对癌症结果(诊断、复发或死亡率)的影响的临床研究中,确定此类生物标志物至关重要。